Pure Global AI
NCT06332417Recruiting

Combined Effects of Ba-Duan-Jin Based Deep Breathing Exercises and Forced Expiratory Technique

Combined Effects of Ba-Duan-Jin Based Deep Breathing Exercises and Forced Expiratory Technique in Patients With Chronic Obstructive Pulmonary Disease
Riphah International UniversityClinicalTrials.govother
Verified
Study focus
Disease/Condition
Chronic Obstructive Pulmonary Disease
Drug/Device/Intervention
Ba-Duan-Jin Based Deep Breathing Exercises
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Riphah International University
Location
Lahore, Pakistan
Timeline & enrollment
Phase
N/A
Start date
Feb 29, 2024
End date
Jun 15, 2024
Enrollment
68 participants
Primary outcome

36-Item Short Form Survey (SF-36),FEV1/FVC ratio,Exercise Tolerance : 6 minute walk test,Forced vital capacity (FVC),Forced expiratory volume (FEV1)

Summary

This study will be a randomized control trial. A total of 68 patients will be recruited and
 randomly assign to the experimental group or the control group in a 1:1 ratio. Participants
 in the experimental group will receive a 8-week Ba-duan jin exercise training intervention
 along with Forced Expiratory Technique at least 3 days a week and 30 minutes a day, while
 participants in the control group will be only given Forced Expiratory intervention and will
 be told to maintain their original lifestyle for 8 weeks along with standard COPD treatment.

ICD-10 classifications
Other chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease, unspecifiedOther specified chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease with acute exacerbation, unspecifiedChronic obstructive pulmonary disease with acute lower respiratory infection
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06332417
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06332417 through Pure Global AI's free database. This phase not specified trial is sponsored by Riphah International University and is currently Recruiting. The study focuses on Chronic Obstructive Pulmonary Disease. Target enrollment is 68 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.